Trade BioNTech ^BNTX

BioNTech (NASDAQ:BNTX) Downgraded by Wall Street Zen to "Sell" - Markets Daily

Why BioNTech (BNTX) Is Down 10.2% After Founders Announce Spinout And mRNA Asset Transfer

BioNTech's (BNTX) "Buy" Rating Reiterated at The Goldman Sachs Group - Markets Daily

BioNTech SE Sponsored ADR $BNTX Shares Acquired by Dodge & Cox

TD Cowen Cuts BioNTech (NASDAQ:BNTX) Price Target to $94.00 - Stock Observer

Assessing BioNTech (NasdaqGS:BNTX) Valuation After Founders' Planned Exit And Weakening COVID-19 Revenues

Best Biotech Stocks To Research - March 13th - Markets Daily

Jefferies Financial Group Cuts BioNTech (NASDAQ:BNTX) Price Target to $138.00 - Stock Observer

Is It Time To Reconsider BioNTech (BNTX) After Its Recent Share Price Weakness?

BioNTech (NASDAQ:BNTX) Given Buy Rating at Canaccord Genuity Group - Markets Daily

Is BioNTech (BNTX) Starting To Look Attractive After Recent Share Price Weakness

BioNTech (NASDAQ:BNTX) Given New $94.00 Price Target at TD Cowen - Daily Political

BioNTech's (BNTX) "Buy" Rating Reiterated at Canaccord Genuity Group

BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar

BioNTech (NASDAQ:BNTX) Given New $130.00 Price Target at Citigroup

BioNTech (NASDAQ:BNTX) Sees Large Volume Increase - Here's What Happened

TD Cowen Has Lowered Expectations for BioNTech (NASDAQ:BNTX) Stock Price

BMO Capital Markets Issues Pessimistic Forecast for BioNTech (NASDAQ:BNTX) Stock Price

BioNTech (NASDAQ:BNTX) Receives "Buy" Rating from The Goldman Sachs Group

US Stock Market Today: S&P 500 Futures Edge Lower As Inflation Jitters Linger

BioNTech SE Sponsored ADR $BNTX Shares Sold by Capital International Inc. CA

BioNTech founders to quit roles to start new venture - Türkiye News

BioNTech Founders to Leave Company by 2026 for New mRNA Venture, ETPharma

Clinical development of cancer vaccines

Founders of German vaccine maker BioNTech to step down, lead new firm

Health Care Down Amid Mixed Earnings - Health Care Roundup | Morningstar

BioNTech Stock Plunges as Founders Leave. Should You Buy the Dip in BNTX Here?

BioNTech (NASDAQ:BNTX) Given New $138.00 Price Target at Jefferies Financial Group

BioNTech founders to leave, launch new company

BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges

Stocks making the biggest moves midday: RIVN, HIMS, KSS, CASY, VRTX

BioNTech founders step down to start new venture - Yahoo News UK

Why BioNTech Stock Is Getting Crushed Today

Analysts' Updated EPS Estimates for March 10th (ADM, ARGX, BNTX, CASY, DAVE, DOM, GFM, KSS, MKS, SBRE) - Daily Political

BioNTech Q4 Earnings Call Highlights | MarketBeat

BioNTech Q4 Earnings Call Highlights - Markets Daily

BioNTech Stock Falls 21% Over Turning To Loss In Q4, Weak FY26 Outlook, Co-Founders Plan To Exit

BioNTech Tumbles as Founding Duo Plan to Leave to Start New Firm

BioNTech (BNTX) Stock Plunges 17% Following Founder Exodus and Disappointing Earnings

BioNTech Slips To Loss In Q4, Warns On Weak FY26 Revenues; Shares Plunge In Pre-market

Scientists behind COVID-19 vaccine will depart BioNTech | Morningstar

BioNTech (NASDAQ:BNTX) Announces Earnings Results, Beats Estimates By $0.18 EPS

Dow Jones Top Company Headlines at 7 AM ET: Bill Ackman's Pershing Square USA Files for IPO | BioNTech ... | Morningstar

BioNTech Repositions From COVID-19 Cash Flows To Oncology-Focused Future

Is BioNTech's (BNTX) Oncology Pivot Rewriting Its Post‑COVID Investment Story?

Assessing BioNTech (BNTX) Valuation After Oncology Pivot And Bristol Myers BNT327 Deal

Is BioNTech SE (BNTX) A Good Stock To Buy Now?

Moderna Settles Patent Dispute for Up to $2.25 Billion, Shares Surge, ETPharma

US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang - The Economic Times

Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang

Is BioNTech (BNTX) Offering Value After Recent Share Price Weakness?

Moderna agrees to pay up to $2.87 billion to settle Covid-19 vaccine patent dispute

TD Asset Management Inc Trims Holdings in BioNTech SE Sponsored ADR $BNTX - Stock Observer

BioNTech (BNTX) Expected to Announce Quarterly Earnings on Monday

BioNTech Stock Forecast | Q4 Results & mRNA Patent Dispute | Capital.com

Primecap Management Co. CA Sells 130,700 Shares of BioNTech SE Sponsored ADR $BNTX - Stock Observer

Pfizer Stock: Is PFE Underperforming the Healthcare Sector?

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Rating of "Moderate Buy" by Brokerages - Markets Daily

Brokerages Set BioNTech SE Sponsored ADR (NASDAQ:BNTX) Price Target at $140.10 - Stock Observer

Raiffeisen Bank International AG Has $1.57 Million Stock Holdings in BioNTech SE Sponsored ADR $BNTX - Daily Political

BioNTech fires shots at Moderna's next-generation vaccine | Americas | Life Sciences Intellectual Property Review

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

BioNTech Takes Legal Action Against Moderna for COVID Vaccine Patent Infringement, ETPharma

FDA Fast Track Win And New HR Chief Might Change The Case For Investing In BioNTech (BNTX)

BioNTech SE (BNTX) Rallying on Solid Oncology Strategy

Aberdeen Group plc Has $28.79 Million Stock Position in BioNTech SE Sponsored ADR $BNTX

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC

BioNtech Stock Forecast 2026-2030 | Future Outlook | Capital.com

Bristol-Myers Squibb Resets Pipeline With RNA Deals And Cost Focus

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: U.S. Inflation Data and BoC Policy Rate in Focus

Moderna share price jumps as Oppenheimer upgrades stock

Pfizer shares sink on lower COVID revenue prospects

5 Stocks to Fall in Love with this Valentines Day

Stocks make further gains as oil bounce carries on

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk